Laboratory officials and racetrack investigators encouraged regulators April 18 to make a bigger commitment to out-of-competition testing and backstretch monitoring to improve the sport's integrity.
The Racing Medication and Testing Consortium board of directors has approved new national laboratory standards for testing, the implementation of a laboratory accreditation program and a new independent Equine Quality Assurance Program.
- By Tom LaMarra
Time and money are two of the major roadblocks as the horse racing industry struggles to come to terms with medication, drug testing, and security, officials said March 4 during the joint annual meeting of Harness Tracks of America and the Thoroughbred Racing Associations.
Testing of post race samples for erythropoietin and darbepoietin antibodies will begin Nov. 1 in New York under an emergency rule approved Oct. 21 by the state's Racing and Wagering Board.
Most Popular Stories
- Archarcharch, Tizway to South Korea
- Look Back: Dr. Fager Delivers on Turf in United Nations
- Better Talk Now Euthanized at Age 18
- After 26 Stakes Wins, Fan Favorite Ben's Cat Retired
- Lights of Medina Leads Pletcher Trio in Mother Goose
- Holy Helena Favored for Queen's Plate
- Curlin's Approval Heads Princess Rooney
- Get your Scorecard, the Travers Trail Has Begun
- Obituary: Jack Arterburn Spent Life in Racing
- Mott Set for Queen's Plate Debut With Channel Maker